At a Sept. 29 gala celebration in Toronto, former LSI Director Dr. Pieter Cullis was announced as the winner of the 2022 Bloom Burton Award.
“We are honoured to recognize Pieter Cullis with the 2022 Bloom Burton Award,” said Jolyon Burton, President of Bloom Burton & Co. in a press release issued by the organization. “Pieter’s determination to understand, formulate and commercialize lipid nanoparticles helped everyone beat back a global pandemic in record time, saving millions of lives, and also having a multitude of other, dramatic therapeutic impacts and advancements.
“It is a privilege to celebrate world-changing Canadian innovation and the Bloom Burton Award does exactly that – recognizing excellence among industry colleagues to continue inspiring future achievements and greatness.”
Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada’s innovative healthcare industry in the previous year. Nominees were accepted from any of the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, services or healthcare IT sectors, and equal consideration was given to contributions across any stage of development – from discovery to commercial-end markets.
Watch a video of the award presentation:
The Bloom Burton Award finalists and winner were chosen by an esteemed panel of judges, all of whom are respected international leaders in healthcare investment, entrepreneurship and journalism:
-
- Michael Altman, Managing Director, Perceptive Advisors
- Christopher Arendt, Head of Oncology Therapeutic Area Unit, Takeda
- Karen Bernstein, Co-Founder and Chairman, BioCentury
- Carl Gordon, Managing Partner, OrbiMed Advisors
- Dennis Purcell, Founder and Senior Advisor, Aisling Capital
- Melinda Richter, Global Head of Johnson & Johnson Innovation – JLABS
- Camille Samuels, Partner, Venrock
All finalists – Frank Baylis & Kris Shah of Baylis Medical Technologies, Jan Skvarka, formerly of Trillium Therapeutics, and Pieter Cullis – were celebrated at the 2022 Bloom Burton Award Gala at the Four Seasons Hotel Toronto on September 29, 2022. Each finalist also received a $25,000 cash prize.
About Bloom Burton & Co.
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, industry and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, as well as advisory on direct investing, company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).